We’re looking forward to joining the global cardiovascular community at the American Heart Association (AHA) Scientific Sessions in New Orleans. Collaboration and connection are key to driving innovation in cardiovascular research, and #AHA25 provides an important forum to engage with peers, share perspectives and stay at the forefront of scientific progress. Discover how we’re helping shape the future of cardiovascular care: https://bit.ly/4nBge0b #OneBMS
Bristol Myers Squibb’s Post
More from this author
Explore content categories
- Career
- Productivity
- Finance
- Soft Skills & Emotional Intelligence
- Project Management
- Education
- Technology
- Leadership
- Ecommerce
- User Experience
- Recruitment & HR
- Customer Experience
- Real Estate
- Marketing
- Sales
- Retail & Merchandising
- Science
- Supply Chain Management
- Future Of Work
- Consulting
- Writing
- Economics
- Artificial Intelligence
- Employee Experience
- Workplace Trends
- Fundraising
- Networking
- Corporate Social Responsibility
- Negotiation
- Communication
- Engineering
- Hospitality & Tourism
- Business Strategy
- Change Management
- Organizational Culture
- Design
- Innovation
- Event Planning
- Training & Development
Founder & Lead Engineer | Crucible Virogenics LLC | Governance‑Native Biotech | Modular Viral Platforms for Translational Medicine, Resilience Engineering, and Public Health Innovation
23hExciting to see Bristol Myers Squibb continuing to invest in cardiovascular innovation and joining the global community at #AHA25. Collaboration really is the engine that drives progress in this field, bringing together diverse perspectives to tackle complex challenges like hypertrophic cardiomyopathy, atrial fibrillation, and heart failure. I’m especially interested in how these sessions will highlight translational pathways, how discoveries in cardiovascular research can be adapted across broader domains of resilience and regenerative medicine. Curious to hear: what areas of cardiovascular care do you see as most ready for paradigm‑shifting innovation in the next decade?